Related content

Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer

By Morgan Robert   Synold Timothy   Gandara David   Muggia Franco   Scudder Sidney   Reed Eddie   Margolin Kim   Raschko James   Leong Lucille   Shibata Stephen   Tetef Merry   Vasilev Steven   McGonigle Kathryn   Longmate Jeff   Yen Yun   Chow Warren   Somlo George   Carroll Mary   Doroshow James  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 4, 2004-10 ,pp. : 283-289

Springer Publishing Company

Access to resources Recommend Favorite

A Phase I/II Study of Topotecan in Combination with Carboplatin in Recurrent Epithelial Ovarian Cancer

By Bolis G.   Scarfone G.   Sciatta C.   Polverino G.P.   Rosa C.   Guarnerio P.   Parazzini F.  

Gynecologic Oncology, Vol. 83, Iss. 3, 2001-12 ,pp. : 477-480

Elsevier

Access to resources Recommend Favorite

A Phase I-II Trial of Fixed-dose Carboplatin and Escalating Paclitaxel in Advanced Ovarian Cancer

By Bolis G.   Scarfone G.   Zanaboni F.   Villa A.   Presti M.   Melpignano M.   Ferraris C.   Tateo S.   Guarnerio P.   Gentile A.   Parazzini F.  

European Journal of Cancer, Vol. 33, Iss. 4, 1997-04 ,pp. : 592-595

Elsevier

Access to resources Recommend Favorite

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with nonsquamous nonsmall cell lung cancer

By  

Oncology Letters, Vol. 8, Iss. 6, 2014-01 ,pp. : 2453-2457

Spandidos Publications

Access to resources Recommend Favorite

Phase I clinical trial of a peptide vaccine combined with tegafur-uracil plus leucovorin for treatment of advanced or recurrent colorectal cancer

By            

Oncology Reports, Vol. 29, Iss. 3, 2013-01 ,pp. : 951-959

Spandidos Publications

Access to resources Recommend Favorite